Mga Batayang Estadistika
| CIK | 1583682 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Antibe Therapeutics Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| May 10, 2021 |
UNITED STATES Securities and Exchange Commission Washington, D.C. 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing (?Filer?): Antibe Therapeutics Inc. B. (1) This is an (check one) x original filing for the Filer. ? amended filing for the Filer. (2) Check the following box if you are filing the Form F-X in paper in accordance with Regula |
|
| May 10, 2021 |
Letter to Shareholders dated May 10, 2021. Exhibit 99.3 Dear Shareholders, This letter supplements the Notice of Special Meeting of Shareholders and Management Information Circular dated May 7, 2021 mailed by Antibe Holdings Inc. to include certain other disclosures relevant to shareholders from a U.S. federal securities laws compliance perspective. Such disclosures include: This exchange offer or business combination is made for the secur |
|
| May 10, 2021 |
Notice of Special Meeting of Shareholders and Management Information Circular dated May 7, 2021. EX-99.2 3 tm2115756d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 ANTIBE HOLDINGS INC. NOTICE OF SPECIAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that a special meeting of shareholders (the “Meeting”) of ANTIBE HOLDINGS INC. (the “Corporation” or “Holdings”) which, due to concerns regarding the novel coronavirus outbreak (COVID-19) and to assist in protecting the health and well-being of our shareho |
|
| May 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form CB TENDER OFFER/RIGHTS OFFERING NOTIFICATION FORM Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to file this Form: Securities Act Rule 801 (Rights Offering) ? Securities Act Rule 802 (Exchange Offer) x Exchange Act Rule 13e-4(h)(8) (Issuer Tender Offer) ? Exchange Act Rule 14d |
|
| May 10, 2021 |
Press Release dated May 7, 2021. Exhibit 99.1 Antibe Therapeutics Announces Agreement to Unify Intellectual Property Ownership - Amalgamation secures 100% ownership of IP underlying Antibe's pipeline - Strengthens position in large-market partnering discussions TORONTO-(BUSINESS WIRE)-May 7, 2021-Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF) ("Antibe" or the "Company"), a clinical stage company leveraging its hydrogen sulfide |
|
| May 10, 2021 |
Exhibit 99.4 ANTIBE HOLDINGS INC. FORM OF PROXY FOR USE AT THE SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 28, 2021 The undersigned shareholder(s) of ANTIBE HOLDINGS INC. (the ?Corporation?) hereby appoint(s) in respect of all of its, his or her shares of the Corporation, Daniel Legault, Chairman or in lieu of the foregoing as nominee of the undersigned, with power of substitution, to attend |
